Long-Acting β(2) Adrenergic Receptor Agonist Ameliorates Imiquimod-Induced Psoriasis-Like Skin Lesion by Regulating Keratinocyte Proliferation and Apoptosis

Psoriasis is a chronic inflammatory disease that affects approximately 1%–5% of the population worldwide. Considering frequent relapse, adverse drug reactions, and large costs of treatment, it is urgent to identify new medications for psoriasis. Keratinocytes play an essential role during psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Rui, Feng, Shi, Ao, Zhou, Chen, Yingxiang, Su, Congping, Feng, Xiuling, Fu, Qin, Yang, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250983/
https://www.ncbi.nlm.nih.gov/pubmed/35795567
http://dx.doi.org/10.3389/fphar.2022.865715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250983/
https://www.ncbi.nlm.nih.gov/pubmed/35795567
http://dx.doi.org/10.3389/fphar.2022.865715

Ejemplares similares